Optometry Practice EBITDA Multiples: 3.0x–5.5x — What Buyers Pay (2026)
From solo retiring ODs to PE-backed roll-ups, here is how acquirers value independent optometry practices across every performance tier.
Independent optometry practices typically trade at 3x–5.5x EBITDA in the lower middle market. Valuations reflect patient base loyalty, insurance payer mix, optical retail revenue, and owner dependence. PE-backed consolidators may pay at the high end for established practices with associate optometrists and modern diagnostic equipment.
Optometry Practice EBITDA Multiples (2026)
| Practice Size | EBITDA Range | Multiple Range | Notes |
|---|---|---|---|
| Entry-Level / Turnaround | $150K–$300K | 3.0x–3.5x | Heavy owner dependence, aging equipment, declining patient volume, or narrow single-payer insurance mix limiting buyer appetite. |
| Stable Independent Practice | $300K–$500K | 3.5x–4.5x | 2,000+ active patients, diversified payer mix, functioning recall system, and clean financials. Core SBA-financed acquisition target. |
| Strong Growth Practice | $500K–$800K | 4.5x–5.0x | Associate optometrists in place, optical retail dispensary, modern OCT and digital refraction technology, and 70%+ patient retention rates. |
| Platform-Ready / PE Target | $800K+ | 5.0x–5.5x | Multi-location or scalable single location with documented systems, diversified revenue, and strong team. Attractive to regional vision care consolidators. |
Valuation Drivers — What Makes Your Multiple Higher or Lower
The spread between 3.5x and 6.5x is not random. These seven factors determine where your firm lands.
Owner Dependence
NegativePractices where all patient relationships rest on the selling OD face steep valuation discounts. Buyers pay a premium when associate optometrists already deliver a significant portion of patient care.
Insurance Payer Mix
Positive or NegativeHeavy reliance on a single managed vision plan like VSP or EyeMed compresses multiples. Diversified payer mix with private pay and optical retail revenue supports higher valuations.
Active Patient Count and Recall Systems
PositivePractices with 2,000+ active patients and documented recall programs achieving 70%+ return rates demonstrate predictable recurring revenue that buyers price at premium multiples.
Optical Retail Revenue
PositiveAn attached dispensary generating eyewear and contact lens sales adds high-margin revenue that pure medical practices lack, materially improving EBITDA margins and supporting higher multiples.
Equipment Age and Capital Needs
NegativeOutdated or fully depreciated diagnostic equipment signals near-term capital expenditure. Buyers discount offers to account for OCT replacement, digital refraction upgrades, or lane modernization costs.
Recent Market Trends
PE-backed vision care platforms have compressed deal timelines and pushed multiples toward the high end for scalable practices. SBA 7(a) lending remains active for OD-to-OD transfers. Buyer demand for telemedicine capability and optical retail revenue has increased as managed care reimbursement rates face compression from VSP and EyeMed contracts.
Who Buys Optometry Practices in 2026
Individual Operator / Search Fund
Entrepreneurship through acquisition (ETA), first-time buyers, industry-adjacent operators
What they want: Stable, transferable cash flow in a Optometry Practice. SBA-eligible business, strong insurance payer mix, and a seller available for a 12–18 month transition.
Pros for seller
- +SBA 7(a) financing means 10% buyer equity — faster than waiting for institutional capital
- +Buyer works inside the business, maintaining client and staff relationships
- +Deal structure is typically straightforward: cash at close plus seller note
Cons for seller
- −Lower multiples than PE buyers — typically at the low-to-mid end of the range
- −Requires meaningful seller involvement post-close for transition
- −SBA approval timeline adds 60–90 days to closing
PE-Backed Roll-Up Platform
Private equity consolidators building a Optometry Practice portfolio, regional or national platforms
What they want: Scale, operational quality, and geographic coverage. Strong insurance payer mix with minimal owner dependence. Clean financials, documented systems, and staff who can operate without the selling owner.
Pros for seller
- +All-cash close with no SBA financing contingency or approval delay
- +Highest multiples available for premium businesses
- +Equity rollover option — seller keeps 10–30% stake and participates in platform exit
Cons for seller
- −Extensive 90–150 day due diligence process
- −Post-close integration into a larger platform changes operating culture
- −Usually requires seller to remain in a leadership role for 12–24 months
Strategic Acquirer
Larger Optometry Practice operators, adjacent-industry buyers adding capacity or geography
What they want: Client relationships, staff, and market position that complement existing operations. Insurance Payer Mix is especially valuable when it fills a gap the buyer cannot build organically.
Pros for seller
- +Can pay above-model multiples for strong strategic fit
- +Buyer already understands the business — diligence moves faster
- +Shorter transition requirement when operational overlap exists
Cons for seller
- −Fewer competing buyers — less negotiating leverage
- −Non-compete scope is typically broader than PE or individual deals
- −Operations and brand may change significantly post-close
Sample Optometry Practice Transactions
Solo OD retirement sale, suburban market, 2,400 active patients, diversified payer mix, clean financials, associate in place for transition
$380K
EBITDA
4.2x
Multiple
$1.6M
Price
Two-location group practice, optical dispensary, OCT and digital refraction technology, associate optometrist employed, PE platform acquisition
$720K
EBITDA
5.1x
Multiple
$3.67M
Price
Single-location practice, heavy VSP concentration, aging equipment, no associate, retiring OD with 18-month transition agreement
$260K
EBITDA
3.3x
Multiple
$858K
Price
EBITDA Valuation Estimator
Get your Optometry Practice business value range instantly
Industry: Optometry Practice · Multiples based on 3.5x–4.5x (Stable Independent Practice)
Powered by DealFlow OS
dealflow-os.com · Free M&A tools for every stage of the deal
How to Use These Multiples
For Sellers: 4-Step Valuation Walkthrough
- 1
Compile three years of P&L statements and tax returns that reconcile line by line — SBA lenders and institutional buyers both require this, and any unexplained gap triggers diligence delays or price renegotiation.
- 2
Build a normalized EBITDA schedule with every add-back documented: owner W-2 above a market-rate manager salary, personal expenses, one-time items, and non-recurring costs. Undocumented add-backs get cut.
- 3
Address your owner dependence before going to market — this is the most common reason Optometry Practice businesses receive offers at the low end of the 3x–5.5x range. Buyers identify it in diligence and reprice accordingly.
- 4
Quantify and document your insurance payer mix with supporting records: contracts, renewal histories, and client revenue breakdowns. This is the primary evidence for commanding a premium multiple — have it ready before the first buyer call.
For Buyers: Validate the Asking Multiple
- 1
Request trailing 12-month and 3-year P&L with bank statement backup before making an offer. If a Optometry Practice seller cannot produce reconciled financials, that signals what the full diligence process will look like.
- 2
Verify the insurance payer mix claims independently — pull contract copies, renewal documentation, and client-level revenue data. This is the primary driver of whether this Optometry Practice is worth 5.5x or 3x.
- 3
Assess owner dependence directly: ask which revenue or client relationships depend on the current owner personally, and what the transition plan is. An exit-ready seller has already worked through this.
- 4
Model your SBA debt service against verified EBITDA before signing the LOI. At current rates, a $1M SBA 7(a) loan runs approximately $13,000/month over 10 years — the business needs at least 1.25x debt service coverage after a market-rate manager salary.
Frequently Asked Questions
What EBITDA multiple should I expect when selling my optometry practice?
Most independent optometry practices sell at 3x–5.5x EBITDA. Your specific multiple depends on patient volume, payer mix, owner dependence, equipment condition, and whether associate optometrists are in place.
Do PE-backed vision care consolidators pay higher multiples than individual OD buyers?
Yes. PE platforms frequently pay 5x–5.5x for scalable practices with associate optometrists and modern equipment, while individual OD buyers using SBA financing typically target 3.5x–4.5x.
How does my optical dispensary affect my practice valuation?
Optical retail revenue significantly improves EBITDA margins and signals revenue diversification. Buyers view dispensary income favorably, often supporting multiples at the higher end of the 3x–5.5x range.
Can I sell my optometry practice using SBA financing?
Yes. Optometry practices are SBA 7(a) eligible. Most OD-to-OD transfers are financed with 80–90% SBA debt, a 10–20% buyer equity injection, and an optional seller note covering 10–15% of the purchase price.
More Optometry Practice Guides
Related Reading
Find Optometry Practice businesses at the right price
DealFlow OS surfaces acquisition targets with seller signals and outreach angles. Free to join.
No credit card required